Cosmetic cross-reference

Pterostilbene

CAS 537-42-8

Pterostilbene (CAS 537-42-8) is a Phase 2 pharmaceutical compound with 10 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

10

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Pterostilbene

CAS Number

537-42-8

UNII

26R60S6A5I

InChIKey

VLEUZFDZJKSGMX-ONEGZZNKSA-N

ChEMBL ID

CHEMBL83527

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL83527 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 10 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	IC50	23762.469677419358 nM	61	-
-	Potency	15560.366666666667 nM	24	-
-	GI50	3.65 ug.mL-1	6	-
-	AC50	55155.6 nM	5	-
-	Ki	1290 nM	5	-
-	EC50	2410 nM	2	-
-	Kd	3250 nM	2	-
-	MIC	41 ug.mL-1	2	-
-	IC50	15.37 ug.mL-1	1	-
-	MIC	31000 nM	1	-

SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

Target	Action	Affinity	PubMed
Peroxisome proliferator-activated receptor-α	Agonist	-	-

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Pterostilbene used for in pharmaceutical contexts?

Pterostilbene (CAS 537-42-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Pterostilbene?

No adverse-event association or SIDER side-effect rows are rendered for Pterostilbene in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Pterostilbene also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Pterostilbene with EU status "permitted".

What clinical phase is Pterostilbene in?

Pterostilbene is rendered with ChEMBL max phase 2.